Mandatum Life Insurance Company’s Edwards Lifesciences EW Stock Holding History

Mandatum Life Insurance Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-55,104	Closed	-$3.2M	–	139
2018 Q3	$3.2M	Sell	55,104 -55,104	-50%	-$2.7M	0.61%	45
2018 Q2	$5.35M	Hold	110,208	–	–	1.03%	10
2018 Q1	$5.13M	Hold	110,208	–	–	0.95%	10
2017 Q4	$4.14M	Hold	110,208	–	–	0.64%	23
2017 Q3	$4.02M	Hold	110,208	–	–	0.54%	20
2017 Q2	$4.34M	Hold	110,208	–	–	0.6%	12
2017 Q1	$3.46M	Hold	110,208	–	–	0.45%	35
2016 Q4	$3.44M	Hold	110,208	–	–	0.47%	29
2016 Q3	$4.43M	Hold	110,208	–	–	0.58%	8
2016 Q2	$3.66M	Hold	110,208	–	–	0.5%	14
2016 Q1	$3.24M	Hold	110,208	–	–	0.44%	20
2015 Q4	$2.9M	Buy	+110,208	New	+$2.86M	0.4%	28

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mandatum Life Insurance Company's EW Position: Q4 2018 in Review

Mandatum Life Insurance Company sold out of Edwards Lifesciences (EW) in Q4 2018, closing a stake of 55,104 shares — an estimated $3.2M sold.

Mandatum Life Insurance Company first reported a position in EW in Q4 2015 and held it in 12 quarters. The position peaked at $5.35M in Q2 2018. 874 funds tracked by Wall St. Rank hold EW as of Q4 2018.

Mandatum Life Insurance Company reported no remaining Edwards Lifesciences position as of Q4 2018 after selling out during the quarter.
Mandatum Life Insurance Company sold 55,104 Edwards Lifesciences shares in Q4 2018, an estimated $3.2M.
Mandatum Life Insurance Company first reported a position in Edwards Lifesciences in Q4 2015 and held it in 12 quarters.
Mandatum Life Insurance Company's Edwards Lifesciences position peaked at $5.35M in Q2 2018.
874 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Mandatum Life Insurance Company's 13F filing for Q4 2018, filed 14 Feb 2019.